TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 1 | 8 | 34 | 62 | 0 | 21 |
| S | %wins | 33 | 67 | 0 | 0 | 0 | 20 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/31/17 17:26 | 8/30/17 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | McMahon John | CO | O | VP,CFO | S.d | -264 | 101.17 | 0 | -3 | -97 | 0 | D | ||||||||||||||
5/25/17 16:48 | 5/23/17 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | McMahon John | CO | O | VP,CFO | S.d | -57 | 97.00 | 0 | -1 | -100 | 0 | D | ||||||||||||||
3/9/17 14:11 | 3/9/17 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | McMahon John | CO | O | VP,CFO | S.d | -69 | 97.42 | 7 | -1 | -90 | 0 | D | 273 | 201 | 73 | 43 | 20 | 15 | 18 | 9 | 3 | 0 | 8 | |||
11/29/16 17:17 | 11/28/16 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | McMahon John | CO | O | VP,CFO | S.d | -131 | 65.64 | 8 | -2 | -98 | 0 | D | 323 | 83 | 81 | 25 | 23 | 8 | 1 | 1 | -2 | -1 | 7 | 36 | ||
8/26/16 11:27 | 8/24/16 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | McMahon John | CO | O | VP,Fin. | S | -7 | 51.30 | 5 | 0 | -100 | 0 | D | 276 | 48 | 55 | 39 | 17 | 2 | 0 | -2 | 2 | 4 | 8 | 31 | 62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |